- Home
- DEI vs PTGX Comparison
DEI vs PTGX Comparison
Compare DEI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DEI | PTGX |
|---|---|---|
| Founded | 1971 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 5.4B |
| IPO Year | 2006 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DEI | PTGX |
|---|---|---|
| Price | $11.11 | $85.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $15.29 | ★ $90.56 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 6.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.12 | ★ 0.72 |
| Revenue | ★ $1,000,336,000.00 | $209,217,000.00 |
| Revenue This Year | $2.82 | N/A |
| Revenue Next Year | $1.67 | $296.47 |
| P/E Ratio | ★ $88.97 | $119.48 |
| Revenue Growth | ★ 3.61 | N/A |
| 52 Week Low | $11.05 | $33.70 |
| 52 Week High | $19.13 | $96.54 |
Technical Indicators
Market Signals| Indicator | DEI | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 28.20 | 47.49 |
| Support Level | $11.58 | $84.11 |
| Resistance Level | $12.16 | $96.54 |
| Average True Range (ATR) | 0.28 | 3.32 |
| MACD | -0.03 | -0.87 |
| Stochastic Oscillator | 1.60 | 18.55 |
Price Performance
Historical ComparisonAbout DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.